MapLight Therapeutics(MPLT) - 2025 Q3 - Quarterly Results
MapLight TherapeuticsMapLight Therapeutics(US:MPLT)2025-12-04 12:03

Exhibit 99.1 MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress SAN FRANCISCO and BOSTON, Dec. 4, 2025 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today reported financial results for the third quarter of 2025 and highlighted recent progress and upcoming milestones. "2025 was a year of exceptional ...